Jeffrey Allen Bailey, Director of Aurinia Pharmaceuticals AUPH, has filed 0 purchases and 1 sale on the open market. The latest trade was on 06/04.

JB

JB

Jeffrey Allen Bailey

Director

Company

Aurinia Pharmaceuticals AUPH

First filing

23/08/21

Trades

10 trades

Buys / sales

0 / 1

12-month net buying

No record

Last trade

06/04

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Aurinia PharmaceuticalsAUPH	Open-market sale	24/11/11	24/11/12	4,557 sh	$8.43	$38,415.51	−25.4%